Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Marek's Disease Vaccine Market Growth 2022-2028

  • LP 4810997
  • 109 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Marek's Disease Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Marek's Disease Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Marek's Disease Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Marek's Disease Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Marek's Disease Vaccine market, reaching US$ million by the year 2028. As for the Europe Marek's Disease Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Marek's Disease Vaccine players cover Merck, Ceva, Zoetis, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Marek's Disease Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Bivalent Vaccine

Monovalent Vaccine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Veterinary Pharmacy

Online Sale

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Ceva

Zoetis

Boehringer Ingelheim

Guangdong Wen's Dahuanong Biotechnology Co., Ltd.

Merial

Ruipu Biopharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Beijing Huadu Shihua Biological Products Co., Ltd.

Guangxi Lichengdong Biological Co., Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Marek's Disease Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Marek's Disease Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Marek's Disease Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Marek's Disease Vaccine Segment by Type

2.2.1 Bivalent Vaccine

2.2.2 Monovalent Vaccine

2.3 Marek's Disease Vaccine Sales by Type

2.3.1 Global Marek's Disease Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Marek's Disease Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Marek's Disease Vaccine Sale Price by Type (2017-2022)

2.4 Marek's Disease Vaccine Segment by Application

2.4.1 Veterinary Pharmacy

2.4.2 Online Sale

2.4.3 Others

2.5 Marek's Disease Vaccine Sales by Application

2.5.1 Global Marek's Disease Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Marek's Disease Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Marek's Disease Vaccine Sale Price by Application (2017-2022)

3 Global Marek's Disease Vaccine by Company

3.1 Global Marek's Disease Vaccine Breakdown Data by Company

3.1.1 Global Marek's Disease Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Marek's Disease Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Marek's Disease Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Marek's Disease Vaccine Revenue by Company (2020-2022)

3.2.2 Global Marek's Disease Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Marek's Disease Vaccine Sale Price by Company

3.4 Key Manufacturers Marek's Disease Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Marek's Disease Vaccine Product Location Distribution

3.4.2 Players Marek's Disease Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Marek's Disease Vaccine by Geographic Region

4.1 World Historic Marek's Disease Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Marek's Disease Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Marek's Disease Vaccine Annual Revenue by Geographic Region

4.2 World Historic Marek's Disease Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Marek's Disease Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Marek's Disease Vaccine Annual Revenue by Country/Region

4.3 Americas Marek's Disease Vaccine Sales Growth

4.4 APAC Marek's Disease Vaccine Sales Growth

4.5 Europe Marek's Disease Vaccine Sales Growth

4.6 Middle East & Africa Marek's Disease Vaccine Sales Growth

5 Americas

5.1 Americas Marek's Disease Vaccine Sales by Country

5.1.1 Americas Marek's Disease Vaccine Sales by Country (2017-2022)

5.1.2 Americas Marek's Disease Vaccine Revenue by Country (2017-2022)

5.2 Americas Marek's Disease Vaccine Sales by Type

5.3 Americas Marek's Disease Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Marek's Disease Vaccine Sales by Region

6.1.1 APAC Marek's Disease Vaccine Sales by Region (2017-2022)

6.1.2 APAC Marek's Disease Vaccine Revenue by Region (2017-2022)

6.2 APAC Marek's Disease Vaccine Sales by Type

6.3 APAC Marek's Disease Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Marek's Disease Vaccine by Country

7.1.1 Europe Marek's Disease Vaccine Sales by Country (2017-2022)

7.1.2 Europe Marek's Disease Vaccine Revenue by Country (2017-2022)

7.2 Europe Marek's Disease Vaccine Sales by Type

7.3 Europe Marek's Disease Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Marek's Disease Vaccine by Country

8.1.1 Middle East & Africa Marek's Disease Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Marek's Disease Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Marek's Disease Vaccine Sales by Type

8.3 Middle East & Africa Marek's Disease Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Marek's Disease Vaccine

10.3 Manufacturing Process Analysis of Marek's Disease Vaccine

10.4 Industry Chain Structure of Marek's Disease Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Marek's Disease Vaccine Distributors

11.3 Marek's Disease Vaccine Customer

12 World Forecast Review for Marek's Disease Vaccine by Geographic Region

12.1 Global Marek's Disease Vaccine Market Size Forecast by Region

12.1.1 Global Marek's Disease Vaccine Forecast by Region (2023-2028)

12.1.2 Global Marek's Disease Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Marek's Disease Vaccine Forecast by Type

12.7 Global Marek's Disease Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Marek's Disease Vaccine Product Offered

13.1.3 Merck Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Ceva

13.2.1 Ceva Company Information

13.2.2 Ceva Marek's Disease Vaccine Product Offered

13.2.3 Ceva Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ceva Main Business Overview

13.2.5 Ceva Latest Developments

13.3 Zoetis

13.3.1 Zoetis Company Information

13.3.2 Zoetis Marek's Disease Vaccine Product Offered

13.3.3 Zoetis Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zoetis Main Business Overview

13.3.5 Zoetis Latest Developments

13.4 Boehringer Ingelheim

13.4.1 Boehringer Ingelheim Company Information

13.4.2 Boehringer Ingelheim Marek's Disease Vaccine Product Offered

13.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boehringer Ingelheim Main Business Overview

13.4.5 Boehringer Ingelheim Latest Developments

13.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.

13.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information

13.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Offered

13.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Main Business Overview

13.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Latest Developments

13.6 Merial

13.6.1 Merial Company Information

13.6.2 Merial Marek's Disease Vaccine Product Offered

13.6.3 Merial Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merial Main Business Overview

13.6.5 Merial Latest Developments

13.7 Ruipu Biopharmaceutical Co., Ltd.

13.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Information

13.7.2 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Offered

13.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview

13.7.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments

13.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

13.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information

13.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Offered

13.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview

13.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments

13.9 Beijing Huadu Shihua Biological Products Co., Ltd.

13.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information

13.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Offered

13.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Main Business Overview

13.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Latest Developments

13.10 Guangxi Lichengdong Biological Co., Ltd.

13.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Information

13.10.2 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Offered

13.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Guangxi Lichengdong Biological Co., Ltd. Main Business Overview

13.10.5 Guangxi Lichengdong Biological Co., Ltd. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Marek's Disease Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Marek's Disease Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Bivalent Vaccine

Table 4. Major Players of Monovalent Vaccine

Table 5. Global Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Marek's Disease Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Marek's Disease Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Marek's Disease Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Marek's Disease Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Marek's Disease Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Marek's Disease Vaccine Revenue by Application (2017-2022)

Table 13. Global Marek's Disease Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Marek's Disease Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Marek's Disease Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Marek's Disease Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Marek's Disease Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Marek's Disease Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Marek's Disease Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Marek's Disease Vaccine Producing Area Distribution and Sales Area

Table 21. Players Marek's Disease Vaccine Products Offered

Table 22. Marek's Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Marek's Disease Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Marek's Disease Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Marek's Disease Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Marek's Disease Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Marek's Disease Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Marek's Disease Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Marek's Disease Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Marek's Disease Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Marek's Disease Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Marek's Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Marek's Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Marek's Disease Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Marek's Disease Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Marek's Disease Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Marek's Disease Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Marek's Disease Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Marek's Disease Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Marek's Disease Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Marek's Disease Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Marek's Disease Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Marek's Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Marek's Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Marek's Disease Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Marek's Disease Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Marek's Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Marek's Disease Vaccine

Table 66. Key Market Challenges & Risks of Marek's Disease Vaccine

Table 67. Key Industry Trends of Marek's Disease Vaccine

Table 68. Marek's Disease Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Marek's Disease Vaccine Distributors List

Table 71. Marek's Disease Vaccine Customer List

Table 72. Global Marek's Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Marek's Disease Vaccine Sales Market Forecast by Region

Table 74. Global Marek's Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Marek's Disease Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Marek's Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Marek's Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Marek's Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Marek's Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Marek's Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Marek's Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Marek's Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Marek's Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Marek's Disease Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Marek's Disease Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Marek's Disease Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Marek's Disease Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Marek's Disease Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Marek's Disease Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Marek's Disease Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Marek's Disease Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Marek's Disease Vaccine Product Offered

Table 94. Merck Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Ceva Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Ceva Marek's Disease Vaccine Product Offered

Table 99. Ceva Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Ceva Main Business

Table 101. Ceva Latest Developments

Table 102. Zoetis Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Zoetis Marek's Disease Vaccine Product Offered

Table 104. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Zoetis Main Business

Table 106. Zoetis Latest Developments

Table 107. Boehringer Ingelheim Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Boehringer Ingelheim Marek's Disease Vaccine Product Offered

Table 109. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Boehringer Ingelheim Main Business

Table 111. Boehringer Ingelheim Latest Developments

Table 112. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Offered

Table 114. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Main Business

Table 116. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Latest Developments

Table 117. Merial Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Merial Marek's Disease Vaccine Product Offered

Table 119. Merial Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Merial Main Business

Table 121. Merial Latest Developments

Table 122. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Offered

Table 124. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Ruipu Biopharmaceutical Co., Ltd. Main Business

Table 126. Ruipu Biopharmaceutical Co., Ltd. Latest Developments

Table 127. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Offered

Table 129. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business

Table 131. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments

Table 132. Beijing Huadu Shihua Biological Products Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Offered

Table 134. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Beijing Huadu Shihua Biological Products Co., Ltd. Main Business

Table 136. Beijing Huadu Shihua Biological Products Co., Ltd. Latest Developments

Table 137. Guangxi Lichengdong Biological Co., Ltd. Basic Information, Marek's Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Offered

Table 139. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Guangxi Lichengdong Biological Co., Ltd. Main Business

Table 141. Guangxi Lichengdong Biological Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Marek's Disease Vaccine

Figure 2. Marek's Disease Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Marek's Disease Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Marek's Disease Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Marek's Disease Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Bivalent Vaccine

Figure 10. Product Picture of Monovalent Vaccine

Figure 11. Global Marek's Disease Vaccine Sales Market Share by Type in 2021

Figure 12. Global Marek's Disease Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Marek's Disease Vaccine Consumed in Veterinary Pharmacy

Figure 14. Global Marek's Disease Vaccine Market: Veterinary Pharmacy (2017-2022) & (K Units)

Figure 15. Marek's Disease Vaccine Consumed in Online Sale

Figure 16. Global Marek's Disease Vaccine Market: Online Sale (2017-2022) & (K Units)

Figure 17. Marek's Disease Vaccine Consumed in Others

Figure 18. Global Marek's Disease Vaccine Market: Others (2017-2022) & (K Units)

Figure 19. Global Marek's Disease Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Marek's Disease Vaccine Revenue Market Share by Application in 2021

Figure 21. Marek's Disease Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Marek's Disease Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Marek's Disease Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Marek's Disease Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Marek's Disease Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Marek's Disease Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Marek's Disease Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Marek's Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Marek's Disease Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Marek's Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Marek's Disease Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Marek's Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Marek's Disease Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Marek's Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Marek's Disease Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Marek's Disease Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Marek's Disease Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Marek's Disease Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Marek's Disease Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Marek's Disease Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Marek's Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Marek's Disease Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Marek's Disease Vaccine

Figure 65. Industry Chain Structure of Marek's Disease Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390